← back to search

Thirusha Lane

Alnylam Pharmaceuticals (United States) ·
Area of research
Molecular Biology · Nephrology
Research interest
Research interests include Amyloidosis: Diagnosis, Treatment, Outcomes, Parathyroid Disorders and Treatments, Inflammasome and immune disorders, and Neuroendocrine Tumor Research Advances.
h-index
33
citations
7,837
works
107
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis
JACC. Cardiovascular imaging 2021cited by 149position: middledoi
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Circulation 2016cited by 1,977position: middledoi
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
Blood 2013cited by 511position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Darren Foard · The Royal Free Hospital1 papers (2013–2013)Andrea Foli · University of Pavia1 papers (2013–2013)Efstathios Kastritis · Frontier Science Foundation-Hellas1 papers (2013–2013)Philip N. Hawkins · The Royal Free Hospital1 papers (2013–2013)Meletios Α. Dimopoulos · Korea University1 papers (2013–2013)Stefan Schönland · University of Pennsylvania1 papers (2013–2013)Julian D. Gillmore · Alnylam Pharmaceuticals (United States)1 papers (2013–2013)Ashutosh Wechalekar · University College Hospital1 papers (2013–2013)Ute Hegenbart · Centre Hospitalier Universitaire de Poitiers1 papers (2013–2013)Giovanni Palladini · Mayo Clinic in Arizona1 papers (2013–2013)Paolo Milani · University of Pavia1 papers (2013–2013)Giampaolo Merlini · Amyloidosis Foundation1 papers (2013–2013)— · 1 papers (2013–2013)